AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

2019 Greece Tumor Marker Sales Segment Forecasts for over 40 Tests: Supplier Shares & Strategies, Volume & Sales Forecasts, Emerging Tests, Technologies & Opportunities - ResearchAndMarkets.com

January 3, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 3, 2020--

The “Greece Tumor Marker Sales Segment Forecasts for over 40 Tests: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Tests, Technologies and Opportunities” report has been added to ResearchAndMarkets.com’s offering.

This new report from the author provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Business Opportunities and Strategic Recommendations

Cancer Diagnostic Tests Analyzed in the Report

Over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines and Immunohistochemical Stains, such as:

Instrumentation Review

Technology Review

Competitive Assessments

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/brmsxv

View source version on businesswire.com:https://www.businesswire.com/news/home/20200103005210/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD: GREECE EUROPE

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/03/2020 08:48 AM/DISC: 01/03/2020 08:48 AM

http://www.businesswire.com/news/home/20200103005210/en